RecruitingNCT06898307

Utility of Gene Test Analysis for Diagnosis, Prognosis and Treatment of Patients With Genetic Arrhythmic Heart Disease: the ARRHYTHMIC GENE-HEART


Sponsor

University Hospital of Ferrara

Enrollment

200 participants

Start Date

Nov 1, 2017

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this observational study is to enroll all patients evaluated at the specialized Cardiogenetic Center within the Cardiology Department of the University of Ferrara, Italy. The primary aim of the registry is to collect comprehensive clinical, genetic, and electrophysiological data from individuals with suspected or confirmed arrhythmogenic conditions. By systematically documenting patient demographics, family history, clinical presentations, diagnostic findings, and treatment outcomes, the registry seeks to enhance our understanding of the genetic basis and clinical implications of genetically driven arrhythmias and systemic syndromes. This registry will facilitate long-term follow-up of enrolled patients to assess the natural history of arrhythmogenic disorders and the effectiveness of various therapeutic interventions. Additionally, it aims to identify potential risk factors associated with adverse outcomes, such as sudden cardiac death or major arrhythmic events.


Eligibility

Inclusion Criteria2

  • Patients evaluated at the Cardiogenetic Center of the University of Ferrara in Ferrara, Italy.
  • Having a proven cardiogenetic disease

Exclusion Criteria2

  • Refuse to provide informed consents
  • Patients not having a cardiogenic disease

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Department of Cardiology, University Hospital of Ferrara

Ferrara, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06898307


Related Trials